home All News open_in_new Full Article

Enveric Biosciences Announces Closing of Exercise of Warrants for $2.2 Million Gross Proceeds

CAMBRIDGE, Mass. — Enveric Biosciences, Inc. (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing next-generation neuroplastogenic small molecules to address psychiatric and neurological disorders, today announced the closing of its previously announced exercise of certain outstanding series A warrants to purchase up to an aggregate of 1,212,499 shares of common stock of the […]


today 2 w. ago attach_file Economics

attach_file Economics
attach_file Economics
attach_file Economics
attach_file Economics
attach_file Other
attach_file Economics
attach_file Economics
attach_file Economics
attach_file Other
attach_file Economics
attach_file Economics
attach_file Sport
attach_file Economics
attach_file Economics
attach_file Economics
attach_file Economics


ID: 4173055135
Add Watch Country

arrow_drop_down